Answers are grounded in this paper and cite their sources.
The intestinal microbiome is an important immune and metabolic organ in health and disease. Recent molecular and metabolomic approaches have provided a better characterization of different types of dysbiosis, including mucosa-adherent bacteria and functional changes in the microbiome. This article summarizes recent advances in assessment of dysbiosis, the importance of the bile acid-converting Clostridium hiranonis as an important beneficial bacterium in the canine gut, and different therapeutic approaches to dysbiosis.
No takes yet. Share an insight, caveat, or question.
Ziese et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: